Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia—a nuclear magnetic resonance study
Authors:
- Katsunori IkewakiKIKatsunori Ikewaki
- Kenji NomaKNKenji Noma
- Jun-Ichiro TohyamaJTJun-Ichiro Tohyama
- Toshimi KidoTKToshimi Kido
- Seibu MochizukiSMSeibu Mochizuki
- 8 June 2005
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 101 (3) , 441-447
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Relationship between Triglyceride Concentrations and LDL Size Evaluated by Malondialdehyde-modified LDLClinical Chemistry, 2001
- Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery DiseaseCirculation, 2000
- Long-term efficacy of bezafibrate in reduction of small, dense low-density lipoprotein by hypotriglyceridemic actionCurrent Therapeutic Research, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)JACC, 1998
- Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in MenCirculation, 1997
- Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemiaAtherosclerosis, 1994